Summary of Study ST002188
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001395. The data can be accessed directly via it's Project DOI: 10.21228/M8DB02 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST002188 |
Study Title | Metabolomic profiling reveals muscle metabolic changes following iliac arteriovenous fistula creation in mice (Lipid) |
Study Type | Study of the skeletal muscle metabolome in mice with iliac arteriovenous fistula via 1H NMR |
Study Summary | In the present study, we hypothesize that the creation of an iliac AVF would result in significant alterations to the limb muscle metabolome. Recently, our group developed a new murine model to address the pathophysiology of access-related hand dysfunction (ARHD) in mice, where AVF creation is performed in the iliac artery/vein. Because of the anatomical location of the AVF creation, this model produces clinically relevant changes in the mouse hindlimb including hemodynamic alterations, muscle weakness, and mitochondrial function impairment. |
Institute | University of Florida |
Department | Applied Physiology and Kinesiology |
Laboratory | Rm 42 and Rm 43 |
Last Name | Ryan |
First Name | Terence |
Address | 1864 Stadium Rd, FLG 114, Gainesville, FL, 32611, USA |
ryant@ufl.edu | |
Phone | 352-294-1700 |
Submit Date | 2022-02-17 |
Num Groups | 4 |
Total Subjects | 34 |
Num Males | All |
Study Comments | Metabolomic study via NMR |
Publications | Frontiers |
Raw Data Available | Yes |
Raw Data File Type(s) | fid |
Analysis Type Detail | NMR |
Release Date | 2022-08-01 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001395 |
Project DOI: | doi: 10.21228/M8DB02 |
Project Title: | Metabolomic profiling reveals muscle metabolic changes following iliac arteriovenous fistula creation in mice |
Project Type: | Study of the skeletal muscle metabolome in mice with iliac arteriovenous fistula via 1H NMR |
Project Summary: | In the present study, we hypothesize that the creation of an iliac AVF would result in significant alterations to the limb muscle metabolome. Recently, our group developed a new murine model to address the pathophysiology of access-related hand dysfunction (ARHD) in mice, where AVF creation is performed in the iliac artery/vein. Because of the anatomical location of the AVF creation, this model produces clinically relevant changes in the mouse hindlimb including hemodynamic alterations, muscle weakness, and mitochondrial function impairment. |
Institute: | University of Florida |
Department: | Applied Physiology and Kinesiology |
Laboratory: | Rm 42 and Rm 43 |
Last Name: | Ryan |
First Name: | Terence |
Address: | 1864 Stadium Rd, FLG 114, Gainesville, FL, 32611, USA |
Email: | ryant@ufl.edu |
Phone: | 352-294-1700 |
Funding Source: | National Institutes of Health (NIH) grant R01HL148597 (STS). Additional salary support was provided by NIH grants R01DK119274 (SAB) and R01HL149704 (TER), and a postdoctoral fellowship (POST903198) from the American Heart Association (KK). |
Project Comments: | Metabolomic study via NMR |
Publications: | Frontiers |
Contributors: | Ram B. Khattri, Kyoungrae Kim, Erik M. Anderson, Brian Fazzone, Kenneth C Harland, Qiongyao Hu, Victoria R. Palzkill, Tomas A. Cort, Kerri A. O’Malle, Scott A. Berceli, Terence E. Ryan, Salvatore T. Scali |
Subject:
Subject ID: | SU002274 |
Subject Type: | Mammal |
Subject Species: | Mus musculus |
Genotype Strain: | C57BL/6J |
Age Or Age Range: | 13 weeks |
Weight Or Weight Range: | (28.4±1.1 g (control SHAM mice) vs 26.4±2.1 g (control AVF mice) vs 23.6±2.1 (CKD SHAM mice) vs 24.7±1.3 (CKD AVF mice), N=8-10/group). |
Gender: | Male |
Animal Animal Supplier: | Jackson Labs (Stock # 000664) |
Animal Housing: | Housed in a temperature of 22 oC |
Animal Light Cycle: | 12-hour light/12-hour dark |
Animal Feed: | Ad libitum (Casein control diet vs. adenine-supplemented diet to induce CKD) |
Animal Water: | free access to food and water (3-5 animals per cage). |
Animal Inclusion Criteria: | (3-5 animals per cage). |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
mb_sample_id | local_sample_id | Factor1*** |
---|---|---|
SA210092 | Terence_MS37_Quad_Org | CKD_AVF |
SA210093 | Terence_MS39_Quad_Org | CKD_AVF |
SA210094 | Terence_MS40_Quad_Org | CKD_AVF |
SA210095 | Terence_MS36_Quad_Org | CKD_AVF |
SA210096 | Terence_MS30_Quad_Org | CKD_AVF |
SA210097 | Terence_MS18_Quad_Org | CKD_AVF |
SA210098 | Terence_MS26_Quad_Org | CKD_AVF |
SA210099 | Terence_MS27_Quad_Org | CKD_AVF |
SA210100 | Terence_MS28_Quad_Org | CKD_AVF |
SA210101 | Terence_MS29_Quad_Org | CKD_AVF |
SA210102 | Terence_MS16_Quad_Org | CKD_SHAM |
SA210103 | Terence_MS20_Quad_Org | CKD_SHAM |
SA210104 | Terence_MS10_Quad_Org | CKD_SHAM |
SA210105 | Terence_MS17_Quad_Org | CKD_SHAM |
SA210106 | Terence_MS9_Quad_Org | CKD_SHAM |
SA210107 | Terence_MS6_Quad_Org | CKD_SHAM |
SA210108 | Terence_MS7_Quad_Org | CKD_SHAM |
SA210109 | Terence_MS8_Quad_Org | CKD_SHAM |
SA210110 | Terence_MS32_Quad_Org | CON_AVF |
SA210111 | Terence_MS35_Quad_Org | CON_AVF |
SA210112 | Terence_MS25_Quad_Org | CON_AVF |
SA210113 | Terence_MS33_Quad_Org | CON_AVF |
SA210114 | Terence_MS24_Quad_Org | CON_AVF |
SA210115 | Terence_MS22_Quad_Org | CON_AVF |
SA210116 | Terence_MS14_Quad_Org | CON_AVF |
SA210117 | Terence_MS23_Quad_Org | CON_AVF |
SA210118 | Terence_MS11_Quad_Org | CON_SHAM |
SA210119 | Terence_MS12_Quad_Org | CON_SHAM |
SA210120 | Terence_MS15_Quad_Org | CON_SHAM |
SA210121 | Terence_MS5_Quad_Org | CON_SHAM |
SA210122 | Terence_MS3_Quad_Org | CON_SHAM |
SA210123 | Terence_MS1_Quad_Org | CON_SHAM |
SA210124 | Terence_MS2_Quad_Org | CON_SHAM |
SA210125 | Terence_MS4_Quad_Org | CON_SHAM |
SA210126 | Sample name | Group |
Showing results 1 to 35 of 35 |
Collection:
Collection ID: | CO002267 |
Collection Summary: | Two weeks after surgery, mice were anesthetized using isoflurane and the left quadriceps muscle was rapidly dissected and immediately frozen in liquid nitrogen and stored at -80oC for metabolite extraction. Euthanasia was carried out by thoracotomy followed by cervical dislocation. |
Sample Type: | Muscle |
Collection Method: | While under isoflurane anesthesia, tissues were rapidly dissected and snap frozen in liquid nitrogen and stored at -80°C until metabolite extraction |
Collection Location: | University of Florida, Applied Physiology and Kinesiology, 1864 stadium RD, Gainesville, FL 32611 |
Storage Conditions: | -80℃ |
Storage Vials: | cryovials |
Treatment:
Treatment ID: | TR002286 |
Treatment Summary: | Briefly, mice were acclimated to a standard casein-based chow (Control Diet) for 7 days. Thereafter, the animals were randomly assign to either remain on Control Diet (non-CKD groups) or receive adenine-supplemented diet to induce CKD. Following three weeks of the casein/adenine diet, animals were randomly assigned to receive either an arteriovenous fistula surgery (AVF) or sham surgery (SHAM) |
Animal Vet Treatments: | none |
Animal Anesthesia: | isoflurane |
Animal Fasting: | non-fasted |
Animal Endp Euthanasia: | Euthanasia was carried out by thoracotomy followed by cervical dislocation. |
Animal Endp Tissue Coll List: | Skeletal muscle (quadriceps) |
Sample Preparation:
Sampleprep ID: | SP002280 |
Sampleprep Summary: | Weights of frozen quadriceps specimens were weighed using a microbalance (Mettler-Toledo, Columbus, OH, USA). Next, a slightly modified FOLCH extraction was performed to extract aqueous and lipid phase metabolites. The aqueous phase was lyophilized overnight (Labconco Corporation, Kansas, MO, USA) and the lipid phase was dried by passing inert nitrogen gas. The resulting aqueous and lipid phase dry powders were stored at -80oC until analysis using nuclear magnetic resonance (NMR). The dry powder of aqueous phase samples was dissolved in 50 µL of phosphate buffer system (50 mM, pH 7.2) consisting of 0.5 mM D6-DSS, 2 mM EDTA and 0.2% NaN2. Lipid phase dry powders were dissolved in 70 µL of CDCl3 supplemented with 10 mM of pyrazine (as internal NMR standard). All samples were loaded into 1.5 mm optical density (O.D.) NMR tubes. |
Sampleprep Protocol Filename: | AVF_NMR_Lipid_phase_Procedures.docx |
Processing Method: | Lyophilization and Homogenization |
Processing Storage Conditions: | -80℃ |
Extraction Method: | Modified FOLCH extraction |
Extract Storage: | -80℃ |
Sample Resuspension: | Deuterated chloroform (80 microliter) with 10 mM pyrazine was used to re-suspend organic phase samples. |
Sample Spiking: | 10 mM of pyrazine for organic phase samples. |
Analysis:
Analysis ID: | AN003582 |
Laboratory Name: | Terence lab, UF |
Analysis Type: | NMR |
Acquisition Date: | 10/01/2021 |
Software Version: | Bruker Topspin |
Operator Name: | Ram Khattri |
Detector Type: | Bruker |
Data Format: | fid, 1r |
Num Factors: | 5 |
Num Metabolites: | 20 |
Units: | A.U. |
NMR:
NMR ID: | NM000240 |
Analysis ID: | AN003582 |
Instrument Name: | Bruker Avance III Cryo800 MHz 54 mm |
Instrument Type: | FT-NMR |
NMR Experiment Type: | 1D-1H |
Field Frequency Lock: | Deuterated chloroform |
Standard Concentration: | 10mM pyrazine |
Spectrometer Frequency: | 799.9 |
NMR Probe: | CP TXI CryoProbe |
NMR Solvent: | Deuterated chloroform |
NMR Tube Size: | 1.5 mm O.D. |
Shimming Method: | Topshim |
Pulse Sequence: | noesypr1d |
Water Suppression: | none |
Pulse Width: | 90-degree |
Receiver Gain: | 228 |
Offset Frequency: | None |
Chemical Shift Ref Cpd: | CDCl3 at 7.26 ppm and pyrazine at 8.61 ppm |
Temperature: | 25 o C |
Number Of Scans: | 128 scans |
Dummy Scans: | 8 |
Acquisition Time: | 4 s |
Relaxation Delay: | 1 s |
Spectral Width: | 9523.8 |
Num Data Points Acquired: | 38094 |
Real Data Points: | 65536 |
Line Broadening: | 0.22 Hz |
Zero Filling: | 65,536 points |
Apodization: | Exponential |
Baseline Correction Method: | Spline |
Chemical Shift Ref Std: | 7.26ppm for CDCl3 |
Binned Increment: | None |
Binned Data Excluded Range: | None |